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To get speedy recovery from any deadly diseases, the most 
important thing is getting proper medication1-9. In the 
passing years, it has been seen that cells and specific genes in 
the human body are acquiring drug resistance capability 
against certain drugs which needs to work correctly for 
getting rid of any particular diseases. Therefore, the 
introduction of nanoparticle and exosomes are gaining 
importance in drug manufacturing units. It is not only 
helping the drug get administered into the exact position 
where it needs to get delivered but also hastening speedy 
recovery of the patient from a lethal disease10-19.  
Numerous methods are used to get rid of the problem like 
drug resistance ability, impassability of drugs through 
intercellular pathways and gene silencing activities.  
It has been seen that few specific cancers like glioblastoma 
are more robust to get diagnosed in the initial stages. Hence, 
during the final stages, it becomes impossible for 
chemotherapeutic drugs to get administered into the exact 
location of the disease.  
Nanoparticles are used in this regard for early detection and 
treatment of such specific brain tumor cases20-31. Apart from 
that, exosomes, as extracellular organelles can be used to get 
proteomic and genetic information from long distance 
intercellular communication. Along with it, exosomes are 
used for proper drug delivery on the exact location where 
the disease is mainly predominant.  
Similarly, psychosis is another fatal disease that is impacting 
thousands of people worldwide. Nanoparticles are used for 
the treatment of this disease for delivering the drug. 
Nanoparticles of 1-500 nanometers are used primarily to 
administer antipsychotic drugs into the human body so that 
the administered drugs can get easily absorbed through the 
blood-brain barrier32-44.    
To control the impact of multidrug resistance among the 
human sometimes excessive amount of drugs get 
administered, but it only causes intolerance of toxicity and 
death of the patient. Along with it, histone modification and 
DNA methylation have been introduced to minimize the 
issues in this regards. Synthesis of oligonucleotides after 
some chemical modification and synthesis of some nano-
sized camptothecin for combined drug delivery are also few 
steps that are getting followed. Doxorubicin (DOX) is the best 
medication used for curing the malignant tumor. Apart from 
that, lung and cervical carcinomas T7 peptide conjugated 
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Figure 2: Chemical Structure of DOX 
 
Different strategies and process have been invented for 
careful drug delivery into the affected areas. To control the 
multi-drug resistance (MDR), the process to introduce 
multiple chemotherapeutic drugs is used nowadays. Apart 
from this, nanoparticles used for antipsychotic disease 
treatment is comparatively low while it is mainly used for 
cancer treatment45-51. This is only for the lack of knowledge 
about psychosis that restricts the drugs from being designed. 
Similarly, safe designing of the EMs cell for gene therapy is 
used for the proper treatment of cancer cells of the human 
body. On the other hand, DNA methylation represses the 
growth and spread of cancer cell for the long term. Non-
small-cell lung cancer (NSCLC) is a lethal form of lung cancer 
that accounts for 80% of total lung cancer cases around the 
world. NSCLC is less responsive for chemotherapy, 
radiotherapy and any treatment.  
References 
1. Kang, C., Qin, J., Osei, W. & Hu, K. Age-dependent Mitochondrial 
Targeting Of Protein Kinase C Epsilon In Cardioprotection. The 
FASEB Journal (2017). 
2. Han, R., Sun, Y., Kang, C., Sun, H. & Wei, W. Amphiphilic 
dendritic nanomicelle-mediated co-delivery of 5-fluorouracil 
and doxorubicin for enhanced therapeutic efficacy. Journal of 
Drug Targeting 2017; 25:140-148. 
3. Yan, G., et al. Application of Real-Time Cell Electronic Analysis 
System in Modern Pharmaceutical Evaluation and Analysis. 
Molecules 23, 3280 (2018). 
4. Duan, Y., et al. Bioactivity evaluation-based ultra high-
performance liquid chromatography coupled with electrospray 
ionization tandem quadrupole-time-of-flight mass 
spectrometry and novel distinction of multi-subchemome 
compatibility recognition strategy with Astragali Radix-Fructus 
Corni herb-pair as a case study. J Pharm Biomed Anal 2016; 
129:514-534. 
5. Sun, Y., et al. Co-delivery of dual-drugs with nanoparticle to 
overcome multidrug resistance. European Journal of BioMedical 
Research 2016; 2:12-18. 
6. Ai, R., et al. Comprehensive epigenetic landscape of rheumatoid 
arthritis fibroblast-like synoviocytes. Nature communications 
2018; 9:1921. 
7. Ai, R., et al. Comprehensive epigenetic landscape of rheumatoid 
arthritis fibroblast-like synoviocytes. Nat Commun 2018; 
9:1921. 
8. Fan, S., et al. Computationally expanding infinium 
HumanMethylation450 BeadChip array data to reveal distinct 
DNA methylation patterns of rheumatoid arthritis. 
Bioinformatics 2016; 32:1773-1778. 
9. Zhu, Y., et al. Constructing 3D interaction maps from 1D 
epigenomes. Nature communications 2016; 7:10812. 
10. Liu, F., Sun, Y. & Kang, C. Controlling Amphiphilic Functional 
Block Copolymers’ Self-Assembly: From Structure to Size. 
(2016). 
11. Song, L., et al. Crocetin inhibits lipopolysaccharide-induced 
inflammatory response in human umbilical vein endothelial 
cells. Cellular Physiology and Biochemistry 2016; 40:443-452. 
12. Sun, Y., Kang, C., Liu, F. & Song, L. Delivery of antipsychotics 
with nanoparticles. Drug Development Research 2016; 77:393-
399. 
13. Kang, C., et al. Delivery of nanoparticles for treatment of brain 
tumor. Current Drug Metabolism 2016; 17:745-754. 
14. Xue, X., et al. Discovery of novel inhibitors disrupting HIF-
1α/von Hippel–Lindau interaction through shape-based 
screening and cascade docking. PeerJ 2016; 4:e2757. 
15. Hersch, S.J., et al. Divergent protein motifs direct elongation 
factor P-mediated translational regulation in Salmonella 
enterica and Escherichia coli. MBio 2013; 4:e00180-00113. 
Kang et al                                                                                                                    Journal of Drug Delivery & Therapeutics. 2019; 9(2):394-396      
ISSN: 2250-1177                                                                                      [396]                                                                                    CODEN (USA): JDDTAO 
16. Hersch, S.J., et al. Divergent protein motifs direct elongation 
factor P-mediated translational regulation in Salmonella 
enterica and Escherichia coli. MBio 2013; 4:e00180-00113. 
17. Shuhong, X., et al. Dynamic expression of AQP4 in early stageof 
ischemia/reperfusion rats and cerebral edema. Chinese 
Pharmacological Bulletin 2016; 32:1433-1441. 
18. Peng, J., et al. Enhanced Liver Regeneration After Partial 
Hepatectomy in Sterol Regulatory Element-Binding Protein 
(SREBP)-1c-Null Mice is Associated with Increased 
Hepatocellular Cholesterol Availability. Cellular Physiology and 
Biochemistry 2018; 47:784-799. 
19. Ngo, V., et al. Epigenomic analysis reveals DNA motifs 
regulating histone modifications in human and mouse. 
Proceedings of the National Academy of Sciences, 201813565 
(2019). 
20. Ngo, V., Wang, M. & Wang, W. Finding de novo methylated DNA 
motifs. bioRxiv, 043810 (2018). 
21. Yang, Z., et al. Functional exosome-mimic for delivery of siRNA 
to cancer: in vitro and in vivo evaluation. Journal of Controlled 
Release 2016; 243:160-171. 
22. Kang, C., Hernandez, V.A. & Hu, K. Functional interaction of the 
two-pore domain potassium channel TASK-1 and caveolin-3. 
Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 
2017; 1864:1537-1544. 
23. Waller, A.P., et al. GLUT12 functions as a basal and insulin-
independent glucose transporter in the heart. Biochimica et 
Biophysica Acta (BBA)-Molecular Basis of Disease 2013; 
1832:121-127. 
24. Li, Q., et al. Identification by shape-based virtual screening and 
evaluation of new tyrosinase inhibitors. PeerJ2018;  6:e4206. 
25. Chen, Y., et al. Identification of 4-aminoquinoline core for the 
design of new cholinesterase inhibitors. PeerJ 2016; 4:e2140. 
26. Kang, C. & Hu, K. Impact of hypoxia in the expression and 
regulation of the TASK-1 potassium channel in cardiac 
myocytes. The FASEB Journal 2016; 30:lb598-lb598. 
27. Fan, S., et al. Integrative analysis with expanded DNA 
methylation data reveals common key regulators and pathways 
in cancers. NPJ genomic medicine 2019; 4:2. 
28. Kang, C. Ion channels, protein kinase C and caveolae in 
cardioprotection, (The Ohio State University, 2015). 
29. HE, L.-y., et al. Isolation and Characterization of Cadmium-
Resistant Endophytic and Rhizobacteria From Solanum nigrum 
in Orefield [J]. Journal of Ecology and Rural Environment 2011; 
6. 
30. Yung, B.C., et al. Lipid nanoparticles composed of quaternary 
amine–tertiary amine cationic lipid combination (QTsome) for 
therapeutic delivery of AntimiR-21 for lung cancer. Molecular 
pharmaceutics 2016; 13:653-662. 
31. Cheng, X., et al. Lipid Nanoparticles Loaded with an Antisense 
Oligonucleotide Gapmer Against Bcl-2 for Treatment of Lung 
Cancer. Pharmaceutical research 2017; 34:310-320. 
32. Fan, S. & Chi, W. Methods for genome-wide DNA methylation 
analysis in human cancer. Brief Funct Genomics 2016; 15:432-
442. 
33. Kang, C. & Hu, K. Modulation of the two-pore domain potassium 
channel TASK-1 by caveolin-3. The FASEB Journal 2015; 
29:845.814. 
34. Davis, M.E., Chen, Z.G. & Shin, D.M. Nanoparticle therapeutics: 
an emerging treatment modality for cancer. Nat Rev Drug 
Discov 2008; 7:771-782. 
35. Kang, C., Sun, Y., Wang, M. & Cheng, X. Nanosized camptothecin 
conjugates for single and combined drug delivery. European 
Journal of BioMedical Research 2016; 2:8-14. 
36. Qiao, H., et al. Orally delivered polycurcumin responsive to 
bacterial reduction for targeted therapy of inflammatory bowel 
disease. Drug Delivery 2017; 24:233-242. 
37. Liu, F., Sun, Y., Kang, C. & Zhu, H. Pegylated Drug Delivery 
Systems: From Design to Biomedical Applications. Nano LIFE 
2016; 6:1642002. 
38. Sun, Y., Kang, C., Yao, Z., Liu, F. & Zhou, Y. Peptide-Based Ligand 
for Active Delivery of Liposomal Doxorubicin. Nano Life 2016; 
6:1642004. 
39. Yeh, C.Y., Hsiao, J.K., Wang, Y.P., Lan, C.H. & Wu, H.C. Peptide-
conjugated nanoparticles for targeted imaging and therapy of 
prostate cancer. Biomaterials 2016; 99:1-15. 
40. Fan, S., Huang, K., Ai, R., Wang, M. & Wang, W. Predicting CpG 
methylation levels by integrating Infinium 
HumanMethylation450 BeadChip array data. Genomics 2016; 
107:132-137. 
41. Qiao, H., et al. Redox-triggered mitoxantrone prodrug micelles 
for overcoming multidrug-resistant breast cancer. Journal of 
drug targeting 2018; 26:75-85. 
42. Kang, C., Qin, J., Osei, W. & Hu, K. Regulation of protein kinase C-
epsilon and its age-dependence. Biochemical and Biophysical 
Research Communications 2017; 482:1201-1206. 
43. Sun, Y., et al. RGD Peptide‐Based Target Drug Delivery of 
Doxorubicin Nanomedicine. Drug development research 2017; 
78:283-291. 
44. Kang, C. & Hu, K. Role of caveolin-3 in adenosine-induced 
increase in mitochondrial PKCε. The FASEB Journal 2013; 
27:1191.1197-1191.1197. 
45. Cheng, X. & Lee, R.J. The role of helper lipids in lipid 
nanoparticles (LNPs) designed for oligonucleotide delivery. 
Adv Drug Deliv Rev 2016; 99:129-137. 
46. Sun, Y. & Kang, C. Self-Assembly of Peptides into Hydrogel. 
Journal of Organic & Inorganic Chemistry 2016; 2:5. 
47. Yao, Z., Sun, Y. & Kang, C. Structure and self-assembly of 
multicolored Naphthalene Diimides Semiconductor. Nano LIFE 
2016; 6:1642007. 
48. Gorkin, D.U., Williams, B.A., Trout, D. & Amrhein, H. Systematic 
mapping of chromatin state landscapes during mouse 
development. (2017). 
49. Zhang, K., Wang, M., Zhao, Y. & Wang, W. Systems-level 
identification of transcription factors critical for mouse 
embryonic development. bioRxiv, 167197 (2017). 
50. Cheng, X., et al. T7 Peptide-Conjugated Lipid Nanoparticles for 
Dual Modulation of Bcl-2 and Akt-1 in Lung and Cervical 
Carcinomas. Molecular pharmaceutics 2018; 15:4722-4732. 
51. Zhong, X., Sun, Y., Kang, C. & Wan, G. The theory of 
dielectrophoresis and its applications on medical and materials 
research. European Journal of BioMedical Research 2017; 2:7-
11. 
 
